Global Colon Cancer Association

GCCA’s CEO @AndrewRSpiegel is speaking on a webinar about the FDA’s user fee program on July 29.    This webinar is brought to you by @patientaccess and @GenericsProject mailchi.mp/allianceforpat…

Biomarkers are pieces of information about your health that can tell your medical team important facts about you and your cancer. Learn about biomarkers, their role in personalized medicine, and their impact on treatment. gcca.info/KYB_What_is_it_ #knowyourbiomarker

Leben Sie mit einem metastasierten kolorektalen Karzinom? #mCRC #darmkrebs

Êtes-vous atteint(e) d'un cancer colorectal métastatique? #CCRm #cancercolorectal

Paid research opportunity alert! If you have been diagnosed with metastatic colorectal cancer and you are living in France, Germany or the United States, contact [email protected] #colorectalcancer #coloncancer #mcrc #CCRm

Curious about clinical trials for colorectal cancer? Learn the basics about how they work, how they can help you, and how you can find a trial right for you. Learn more: gcca.info/_CTA_Curious #clinicaltrials #colorectalcancer #linkinbio

We are proud to announce the 12 recipients of GCCA’s 2025 CRC Health Equity Grants. Thank you to @bmsnews Bristol Myers Squibb, @Bayer , and @ExelixisInc for their sponsorship of the 2025 CRC Health Equity Grants! For more about the 2025 CRC Health Equity Grant projects,…

Everyone with colorectal cancer should have biomarker testing. The exact biomarker tests needed can vary by what cancer stage you have, your personal and family cancer history, and the results of any previous biomarker testing. For more information about what biomarker tests you…

New on the blog, learn about DPD deficiency and why it’s important in colorectal cancer treatment. And hear about the work of GCCA member Advocates for Universal DPD/DPYD Testing @test4dpyd . Read the blog here: gcca.info/Blog_Post_7_09… #colorectalcancer #dpddeficiency #dpyd #5FU

New on the GCCA blog, Nicole Sheahan, GCCA President, shares highlights from the Fight CRC Global Early Onset Colorectal Cancer Think Tank in Barcelona. Read the blog here: gcca.info/_Blog_Post_7_0… #eocrc #colorectalcancer #advocacy #geocrctt

Also known as standard therapy or best practice, standard of care is the treatment that is widely accepted by medical experts as the correct treatment for a disease. Learn more terms used in talking about clinical trials with our glossary here: gcca.info/CTA_standard_o… #linkinbio…

Please welcome our newest member, @ButaroHospital Butaro Cancer Center of Excellence (BCCOE). The BCCOE is a specialized cancer treatment facility located in a rural area of Rwanda, more than 100 km from the capital city, Kigali. Learn more: gcca.info/Welcome_BCCOE_

The U.S. Senate has just passed legislation that will cause millions of patients to lose their health insurance through Medicaid and marketplace plans, which will cut patients off from necessary cancer screenings, testing, and treatments. Contact your House members here:…

Meet Nomfundo who is living with stage IV early-onset colorectal cancer. Watch her whole story from diagnosis to treatment and hear her share about the struggles and strength she has experienced as a young mother with cancer. gcca.info/Patient_Story_… #eocrc #colorectalcancer…

NTRK fusion is a genetic mutation associated with several solid tumor types, including colorectal cancer. TRK inhibitor drugs may be useful in treating cancers with NTRK fusion. Learn more: gcca.info/KYB_ntrk_Fusion #colorectalcancer #knowyourbiomarker #ntrkfusion

New on the GCCA Blog, learn about a recent immunotherapy policy change in Taiwan and the work of GCCA member, Taiwan Young Patient Association. Read the blog here: gcca.info/Blog_Post_6_25…

Please welcome our newest member, @kenya_ostomy Kenya Ostomy Association (KOA). KOA is a registered nonprofit organization providing essential supplies, education and support to Ostomates in East Africa. Learn more: gcca.info/_Welcome_Kenya…

Cancer patients can't afford policies that delay access to life-saving drugs. @‌POTUS's #MFN rule would do just that. @AndrewRSpiegel, CEO of the Global Colon Cancer Association has co-written an op-ed with Marcia K. Horn, president and CEO of @WarOnCancer, in which they explain…

For patients who cannot participate in a clinical trial, expanded access is a way to get access to a treatment that is still being studied when other treatment options aren’t available. It is also known as compassionate use. Learn more: gcca.info/_CTA_expanded_……